Purchase Order 36C26326P0230

Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and a self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis) on January 30, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, with an ultimate completion date of March 1, 2026, carries no set-aside designation and represents a sole-source procurement reflecting the contractor's exclusive manufacturing capability for the specified cardiac medical technology. The award is structured as a purchase order under the Department of Veterans Affairs' healthcare procurement framework to support specialized cardiac care for the veteran population.

This contract represents a continuation of Edwards Lifesciences LLC's substantial business relationship with the VA, which has awarded the company over 200 prime federal contracts since 2025, consisting predominantly of firm fixed-price purchase orders across multiple Veterans Integrated Service Networks. The company's TAVR systems and other transcatheter heart valve products are essential to the VA's cardiac surgical programs. Edwards Lifesciences LLC also maintains two indefinite delivery contracts with the VA totaling $7.45 million—a $6.5 million five-year surgical implant consignment agreement with VISN 21 and a $950,000 five-year cardiovascular devices contract with VISN 15—which establish the company as the primary framework supplier of advanced cardiovascular devices across key VA service network partners.